The initial goal is to ascertain the pharmacokinetic (PK) profile of CBD (cannabidiol) after
a single dose of CBDE (cannabidiol extract), although the plan is to extend these studies to
multiple dose administrations in the future, since it is likely that (cannabidiol) and/or its
metabolites will show some accumulation. These studies will provide detailed information that
will inform the continuation and expansion of CBDE in other research projects.